Carcinogenicity
GARDASIL has not been evaluated for carcinogenic potential.
Genotoxicity
GARDASIL has not been evaluated for genotoxic potential.
Paediatric Use
The safety and efficacy of GARDASIL have not been evaluated in children younger than 9 years.
Use with Other Vaccines
Results from clinical studies indicate that GARDASIL may be administered concomitantly (at a separate injection site) with hepatitis B vaccine (recombinant). GARDASIL has not been studied in clinical trials with other vaccines.
49 pages.